|1.||Pachón, J: 10 articles (05/2013 - 04/2000)|
|2.||Pichardo, C: 9 articles (07/2011 - 04/2000)|
|3.||Giacometti, Andrea: 7 articles (12/2013 - 07/2002)|
|4.||Cirioni, Oscar: 7 articles (12/2013 - 07/2002)|
|5.||Pachón-Ibáñez, M E: 7 articles (07/2011 - 10/2004)|
|6.||Caillon, Jocelyne: 6 articles (09/2014 - 10/2004)|
|7.||Potel, Gilles: 6 articles (09/2014 - 10/2004)|
|8.||Ghiselli, Roberto: 6 articles (12/2013 - 07/2002)|
|9.||García-Curiel, A: 6 articles (07/2011 - 04/2000)|
|10.||Jiménez-Mejías, M E: 6 articles (05/2010 - 04/2000)|
04/01/2005 - "Imipenem seems to be the most effective agent for the therapy and control of the spread of infections caused by ESBL-producing bacteria. "
01/01/1991 - "The intramuscular imipenem formulation has been proven to be effective for mild to moderate infections of many body sites, as demonstrated by other papers in this symposium. "
04/04/1990 - "These good or very good clinical results show that imipenem is effective in the treatment of severe infections observed in intensive care units."
01/01/2010 - "Imipenem on its own showed no difference in the incidence of mortality, but there was a significant reduction in the rate of pancreatic infection (p=0.02; RR 0.34, 95% CI 0.13 to 0.84). "
12/01/1998 - "Imipenem proved significantly more effective in prevention of pancreatic infections (P </= 0.05). "
06/01/2014 - "A case of pneumonia caused by Legionella pneumophila serogroup 12 and treated successfully with imipenem."
04/01/2003 - "Our modified rapid imipenem desensitization protocol was successful and allowed for effective treatment of life-threatening pneumonia."
06/15/1998 - "Low dose imipenem could be effective and safe in uncomplicated cases without pneumonia. "
01/01/2010 - "Of the 46 studies identified, 20 (N = 4,310) included patients with pneumonia (imipenem 1,667, PA 251; comparator 1,661, PA 270). "
01/01/2010 - "We conducted a systematic literature review of randomized controlled trials (RCT) of imipenem treatment for pneumonia published in English between 1993 and 2008. "
05/01/1988 - "Those results demonstrate the efficacy of imipenem in the treatment of septicemia in newborns due to multiresistant Gram negative bacteria."
07/01/1985 - "Efficacy of imipenem was shown in animal models, including septicemia in normal and neutropenic rodents and P. "
05/01/2015 - "The clearance rate of imipenem is increased significantly in vitro under the mode of CVVH with the actual dose of replacement fluid was (31.63±1.48) mL×kg⁻¹×h⁻¹ in severe infective patients with severe sepsis complicating AKI, affecting the level of plasma drug concentration, need to adjust the dosage regimen. "
07/01/2014 - "This epidemic clonal group was more frequently resistant to imipenem and was associated with an increased risk of sepsis, although not with severe sepsis or mortality. "
01/01/2013 - "Impact of imipenem treatment on colonic mycobiota in rats with double-hit sepsis."
01/01/2014 - "The purpose of this paper is to report outcomes of intravitreal imipenem in the treatment of multidrug-resistant Klebsiella-related postoperative endophthalmitis. "
04/01/2012 - "Experimental rabbit endophthalmitis model caused by imipenem resistant A. "
07/01/2002 - "Prophylactic intravenous imipenem can prevent or significantly reduce the severity of experimental endophthalmitis."
07/01/2002 - "Intravenous imipenem prophylaxis in experimental endophthalmitis."
04/01/1994 - "These levels were above the minimum inhibitory concentration of imipenem for 90% (MIC 90) of the main species responsible for endophthalmitis."
05/01/1992 - "Successful use of higher-than-recommended dosage of imipenem in Pseudomonas aeruginosa endocarditis."
01/01/1992 - "Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem."
10/01/1987 - "Hospital acquired native valve endocarditis caused by Acinetobacter calcoaceticus and treated with imipenem/cilastin."
05/01/1986 - "Imipenem was evaluated for its activity against Staphylococcus epidermidis in vitro and in a rabbit model of endocarditis. "
05/01/1986 - "Imipenem therapy of experimental Staphylococcus epidermidis endocarditis."
|1.||Drug Therapy (Chemotherapy)
|2.||Intensive Care (Surgical Intensive Care)
|4.||Artificial Respiration (Mechanical Ventilation)
|5.||Continuous Ambulatory Peritoneal Dialysis (CAPD)